![](/img/cover-not-exists.png)
Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab into Clinical Practice
Sanford, David S., Wierda, William G., Burger, Jan A., Keating, Michael J., O'Brien, Susan M.Volume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.02.019
Date:
July, 2015
File:
PDF, 248 KB
english, 2015